Back
Jasper Therapeutics 10K Form
Sell
49
JSPR
Jasper Therapeutics
Last Price:
$5.57
Seasonality Move:
-11.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive JSPR News And Ratings
See the #1 stock for the next 7 days that we like better than JSPR
JSPR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-22.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.81 |
| Price / Book: | 1.98 |
Profitability
| EPS (TTM): | -5.24000 |
|---|---|
| Net Income (TTM): | $-78.8M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Jasper Therapeutics Earnings Forecast
Key Jasper Therapeutics Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 2 years.
Jasper Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | JSPR |
| Website: | jaspertherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
JSPR Technical Analysis vs Fundamental Analysis
Sell
49
Jasper Therapeutics (JSPR)
is a Sell
Is Jasper Therapeutics a Buy or a Sell?
-
Jasper Therapeutics stock is rated a SellThe current Jasper Therapeutics [JSPR] share price is $5.57. The Score for JSPR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.